close
MENU
Hot Topic Reporting season
Hot Topic Reporting season
Tech & Innovation
4 mins to read

Upstream Medical Technologies raises $2m to end discovery phase

The health tech company is developing biomarkers to help treat patients with chest pain.

Professor Chris Pemberton has become VP of discovery.

Upstream Medical Technologies, which is developing novel biomarkers for heart disease, has raised $2 million in its latest capital round to take it from discovery to commercial development.

The $2m investment was led by existing deep tech investor Pacific Channel and included $262,500 from new

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
Fiona Rotherham Thu, 18 May 2023
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Upstream Medical Technologies raises $2m to end discovery phase
Tech & Innovation,
99088
true